Citius Pharmaceuticals Inc (CTXR) Stock Price Today
Aura AI Summary
Key Stats
- $16.19MMarket Cap
- -Volume
- HealthSector
- $1.8252W High
- $0.4852W Low
- -Typical Hold Time
- $6.36MEnterprise Value
- -Div Yield
- -Trading Activity
Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.48 and a high of $1.82, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Most Recent News
New rate hike boosts American Water's revenue by $68M, fueling $1.4B infrastructure upgrades and analyst optimism.
New Jersey American Water received approval for rate increases that will add $68 million annually to its revenue. This funding supports over $1.4 billion in critical infrastructure upgrades, including replacing aging water mains and improving treatme...

Law firm probes Stryker for possible securities law breaches after conflicting manufacturing updates.
Block & Leviton is investigating Stryker Corporation for potentially misleading investors about a manufacturing issue affecting its peripheral vascular business. Initially, Stryker's CEO claimed the problem was resolved and expected to be fixed in Q3...

Korn Ferry shifts to durable revenue with consulting and AMS acquisition, boosting backlog to $3.4B.
Korn Ferry has expanded beyond executive search into consulting and workforce solutions, including acquiring AMS, to reduce cyclicality and increase revenue stability. The company now has a backlog of $1.9 billion from its core business and $1.5 bill...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.